More stories
Pα+ Psychedelic Bulletin #182: Psychedelics Insiders’ Trump 2.0 Wishlist; Doblin Reflects on Lykos’ Strategy;...
As some of us draw up our wishlists for Santa’s perusal (though, apparently Saint Nicholas has been found a little worse for wear in...
Regulation, Decriminalization, and Religious Freedom: Prop 122’s Challenges and Opportunities
In this episode, Joe interviews Veronica Lightning Horse Perez: therapist, speaker, author, activist, and co-chief proponent for the Natural Medicine Health Act of 2022...
Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future...
In our latest interview, Psychedelic Alpha’s Josh Hardman speaks with Javier Muniz, MD, who recently left his post as Associate Director at the FDA’s...
How Family Healing Shapes Veteran Recovery
In this episode, Joe interviews two members of the Heroic Hearts Project: Founder and President, Jesse Gould; and Director of Development and Head of...
Prophecy, Psychedelics, and Power in Dune
Join us for a thought-provoking exploration of Frank Herbert’s Dune series, focusing on the spice melange as a symbol of spiritual transcendence and systemic...
Psychedelic Drug Development Under Trump 2.0: Health Nominees Signal Uncertain Future
As Donald Trump rounds out his nominations for key positions in his incoming administration, we’re keeping an eye on how his health-related picks might...
Is Cannabis a Psychedelic? Exploring the Science of Indoles, Interprening, and Intention
Most cannabis enthusiasts have experienced the wide range of possible effects, from a subtle happy high to one that floors you. The question must...
Q3’24 Survey: What are Psychedelics Investors Concerned About?
Earlier, we shared the high-level results of our Q3’24 Psychedelic Investor Survey, our third such survey. We also shared what investors are most excited...
Interviews: Meet the Team Who Challenged the DEA on DOI and DOC
By Dr. Alaina M. Jaster The DEA hearing to challenge the scheduling of two phenethylamine psychedelics, DOI and DOC, began on what many would...
The 3-Axis Framework: A New Model for Psychedelic Integration
New ways of looking at non-ordinary experiences and integration are always being conceived. What is the 3-axis framework? In this episode, Kyle interviews Pierre...
Q3’24 Survey: What are Psychedelics Investors Excited About?
Earlier, we shared the high-level results of our Q3’24 Psychedelic Investor Survey, our third such survey. Here, we take a closer look at investors’...
Pα+ Psychedelic Bulletin #181: Last-Minute Changes to Colorado’s Psychedelics Rules; Cybin’s Impressive 12-Month Data...
As Colorado’s state-regulated psychedelics system comes ever closer to its launch next year, last-minute changes to its rules are causing commotion. With fewer than...
